Research suggests that Arjuna (Terminalia arjuna) appears in the broader scientific literature on plant-based approaches to blood pressure regulation, though the available evidence directly examined here consists of a single 2021 review article that surveyed a wide range of medicinal plants with antihypertensive potential, with Arjuna included among many candidates rather than being a primary focus. The review drew on animal studies, human trials, and laboratory experiments across numerous botanicals, noting that herbal medicines have a long history of traditional use for hypertension management and that a substantial portion of the global population relies on plant-based remedies. Studies indicate that the general direction of this type of review is supportive of further investigation into plant-derived compounds, but the broad, multi-herb scope of this particular source limits how much can be concluded specifically about Arjuna's effects on blood pressure. The evidence base here is preliminary and indirect, and more targeted clinical research, such as randomized controlled trials focused specifically on Arjuna, would be needed to draw firmer conclusions about its role in blood pressure regulation.
Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.
| Title | Type | Year | Direction | Match |
|---|---|---|---|---|
| Plants Used as Antihypertensive. | Review | 2021 | — | 100 |